GILEAD SCIENCES, INC. Quarterly Costs and Expenses in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Gilead Sciences, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q2 2024.
  • Gilead Sciences, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $4.31B, a 12.7% decline year-over-year.
  • Gilead Sciences, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $25.2B, a 33.5% increase year-over-year.
  • Gilead Sciences, Inc. annual Costs and Expenses for 2023 was $19.5B, a 2.21% decline from 2022.
  • Gilead Sciences, Inc. annual Costs and Expenses for 2022 was $20B, a 14.7% increase from 2021.
  • Gilead Sciences, Inc. annual Costs and Expenses for 2021 was $17.4B, a 15.7% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $25.2B $4.31B -$625M -12.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $25.9B $11B +$6.36B +137% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $19.5B $5.5B +$380M +7.42% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $19.1B $4.43B +$223M +5.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $18.9B $4.93B +$703M +16.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $18.2B $4.65B -$1.75B -27.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $20B $5.12B -$1.18B -18.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $21.1B $4.21B +$626M +17.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $20.5B $4.23B +$260M +6.55% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $20.2B $6.39B +$2.86B +81% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $17.4B $6.3B +$1.53B +32.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $15.9B $3.58B -$997M -21.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $16.9B $3.97B -$4.16B -51.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $21B $3.53B +$387M +12.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $20.6B $4.77B -$16M -0.33% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $20.6B $4.58B -$2.5B -35.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $23.1B $8.13B +$4.87B +150% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $18.3B $3.15B +$102M +3.35% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $18.2B $4.79B +$135M +2.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $18B $7.08B +$4.1B +138% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $13.9B $3.26B -$113M -3.36% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $14B $3.04B +$109M +3.71% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $13.9B $4.65B +$993M +27.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $12.9B $2.97B +$273M +10.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $12.7B $3.37B +$481M +16.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $12.2B $2.94B +$197M +7.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $12B $3.66B +$383M +11.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $11.6B $2.7B -$401M -12.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $12B $2.89B -$351M -10.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $12.4B $2.74B -$405M -12.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $12.8B $3.28B +$390M +13.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $12.4B $3.1B +$391M +14.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $12B $3.24B +$610M +23.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $11.4B $3.14B +$920M +41.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $10.4B $2.89B -$99M -3.32% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $10.5B $2.71B +$148M +5.78% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $10.4B $2.63B +$505M +23.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $9.89B $2.22B +$267M +13.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $9.63B $2.98B +$1.06B +55.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $8.56B $2.56B +$927M +56.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $7.64B $2.12B +$509M +31.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $7.13B $1.96B +$450M +29.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $6.68B $1.92B +$442M +29.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-24
Q3 2013 $6.24B $1.63B +$252M +18.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $5.98B $1.61B +$267M +19.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $5.72B $1.51B +$24.1M +1.63% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $5.69B $1.48B +$148M +11.1% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $5.54B $1.38B +$265M +23.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 $5.28B $1.35B +$226M +20.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $5.05B $1.48B +$458M +44.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $4.6B $1.33B +$164M +14% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $4.43B $1.12B +$159M +16.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $4.27B $1.12B +$186M +19.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 $4.09B $1.02B +$99.4M +10.8% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 $3.99B $1.17B Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $959M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $935M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 $925M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.